Australia's Clinuvel Pharmaceuticals falls on weak HY profit

Clinuvel Pharmaceuticals

26/02/2026 03:57

** Clinuvel Pharmaceuticals CUV.AX falls as much as 3.4% to A$11.02, lowest since February 18

** Co posts HY profit after tax attributable of A$10.4 million ($7.4 million), down 26% y/y

** However, co logs HY revenue of A$36.9 million, up 4% y/y

** YTD, CUV down 9.6% YTD

($1 = A$1.4039)

 (Reporting by Aamir Shaik Khalid in Bengaluru)

 ((Aamir.SheikKhalid@thomsonreuters.com;))